You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Residual disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Using Mass Spectrometry Detecting Minimal Residual Disease in

Recruiting
  • Multiple Myeloma
    • Tianjin, China
      InsituteHBDH
    Sep 8, 2022

    High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

    Not yet recruiting
    • High Risk CLL
    • Chronic Lymphocytic Leukemia
    • VenObi+Ven or VenObi+VenZan
    • (no location specified)
    Jul 26, 2022

    Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)

    Not yet recruiting
    • Breast Cancer
    • HER2-positive Breast Cancer
    • Toronto, Ontario, Canada
      University Health Network: Princess Margaret Cancer Centre
    Oct 31, 2022

    Minimal Residual Disease in Peripheral T-cell Lymphoma

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Tumor biopsy
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Dec 19, 2022

    Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

    Not yet recruiting
    • Colorectal Cancer
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 31, 2023

    AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • CD33/CLL1 dual CAR-NK cell
    • +5 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 4, 2023

    Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +1 more
    Jan 31, 2023

    Locally Advanced Head and Neck Carcinoma Trial in Grenoble, Lyon, Saint-Étienne (Blood sample)

    Not yet recruiting
    • Locally Advanced Head and Neck Carcinoma
    • Blood sample
    • Grenoble, France
    • +2 more
    Jan 24, 2023

    Residual Disease in Breast Cancer Remission After Primary

    Recruiting
    • Breast Cancer
    • minimally invasive preoperative image-guided vacuum-assisted biopsy
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Jul 10, 2023

    AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • chidamide and azacitidine
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Sep 27, 2023

    Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Ann Arbor, Michigan
    • +3 more
    Jan 19, 2023

    ctDNA-based Minimal Residual Disease Detection for Resected

    Not yet recruiting
    • Pancreatic Cancer Resectable
    • ctDNA-based MRD detection
    • Shanghai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiao Tong University Scho
    Jul 29, 2022

    Multiple Myeloma Minimal Residual Disease

    Completed
    • Multiple Myeloma
    • blood samples and bone marrow aspirates will be collected
    • Lille, France
    • +2 more
    Sep 2, 2022

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)

      Not yet recruiting
      • Acute Lymphocytic Leukemia
      • Inotuzumab ozogamicin
      • (no location specified)
      Jul 11, 2022

      Cervical Cancer Trial in Chongqing (salvage surgery)

      Recruiting
      • Cervical Cancer
      • salvage surgery
      • Chongqing, Chongqing, China
        Chongqing Cancer Hospital
      Feb 20, 2023

      Esophageal Cancer Trial (Blood sample)

      Not yet recruiting
      • Esophageal Cancer
      • Blood sample
      • (no location specified)
      Jan 19, 2023

      Multiple Myeloma Trial (Isatuximab, Lenalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Apr 19, 2022

      Strategy for Resected NSCLC Longitudinal Undetectable MRD

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Molecular residual disease test
      • (no location specified)
      Jul 9, 2022

      Colorectal Cancer Trial in Houston (TAS-102)

      Recruiting
      • Colorectal Cancer
      • Houston, Texas
        MD Anderson Cancer Center
      Jun 7, 2022

      Minimal Residual Disease in Gastric Cancer by Liquid Biopsy

      Recruiting
      • Gastric Cancer
      • ctDNA
      • ctDNA
      • Ho Chi Minh City, Vietnam
        University Medical Center Ho Chi Minh City
      Apr 27, 2022

      MRD Detection by NGS in Pediatric B-ALL

      Completed
      • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
      • MRD
      • Hangzhou, Zhejiang, China
        The Children's Hospital of Zhejiang University School of Medicin
      Jul 25, 2023

      Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)

      Recruiting
      • Pediatric ALL, B Cell
      • Minimal Residual Disease
      • Blinatumomab for Injection
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Feb 20, 2022

      Nsclc Trial in Montpellier (Blood sample)

      Recruiting
      • Nsclc
      • Blood sample
      • Montpellier, France
        University Hospital
      Apr 27, 2022

      Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

      Recruiting
      • Gastrointestinal Stromal Tumors
      • Minimal Residual Disease
      • liquid biopsy
      • Beijing, Beijing, China
        Peking University People'S Hospital
      Sep 18, 2022